Coya Therapeutics, Inc.
- COYA
- NASDAQ
- Biotechnology
- Biotech (Treg Modulation)
- Immunotherapy
$4.25
Today −2.07%Quote Oct 16, 2026, 08:00 PM UTC
−10.71%over the last month
Max drawdown −21.1%From 1-month high −19.8%3 months −4.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$99.7M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$12.00
+182.4% from here
Floor
$4.19
1.5% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about COYAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
8